Order Article Reprints

Zha L, Zhang X, Cheng Y, Xu Q, Liu L, Chen S, Lu Z, Guo J, Tefsen B. Intravenous Polymyxin B as Adjunctive Therapy to High-Dose Tigecycline for the Treatment of Nosocomial Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae: A Propensity Score-Matched Cohort Study. Antibiotics. 2023; 12(2):273. https://doi.org/10.3390/antibiotics12020273

Zha, Lei, Xue Zhang, Yusheng Cheng, Qiancheng Xu, Lingxi Liu, Simin Chen, Zhiwei Lu, Jun Guo, and Boris Tefsen. 2023. "Intravenous Polymyxin B as Adjunctive Therapy to High-Dose Tigecycline for the Treatment of Nosocomial Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae: A Propensity Score-Matched Cohort Study" Antibiotics 12, no. 2: 273. https://doi.org/10.3390/antibiotics12020273

Zha, L., Zhang, X., Cheng, Y., Xu, Q., Liu, L., Chen, S., Lu, Z., Guo, J., & Tefsen, B. (2023). Intravenous Polymyxin B as Adjunctive Therapy to High-Dose Tigecycline for the Treatment of Nosocomial Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae: A Propensity Score-Matched Cohort Study. Antibiotics, 12(2), 273. https://doi.org/10.3390/antibiotics12020273